Impact Of Hospital-Acquired Infections On The Catheter-Related Bloodstream Infection Market Driver: A Major Catalyst in the Evolution of the Catheter-Related Bloodstream Infection Market in 2025

How Is the Catheter-Related Bloodstream Infection Market Projected to Grow, and What Is Its Market Size?
The market for catheter-related bloodstream infections has seen robust growth in the past few years. The industry is projected to upscale from $1.53 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The previous growth can be linked to factors such as the increasing prevalence of chronic illnesses, improved awareness and education, the surge in hospital-acquired infections, the expanding senior population, and improved infection control protocols in medical institutions and healthcare facilities.

Anticipated robust growth in the catheter-related bloodstream infection market is set to increase its size to $2.05 billion by 2029, revealing a compound annual growth rate (CAGR) of 6.0%. Influential factors driving this growth in the forecasted period include a rise in healthcare-associated infections (hais), heightened awareness and educational initiatives, the amplification of training programs focusing on infection control practices, as well as expanded healthcare infrastructures. Additionally, the upswing of the elderly population and supportive governmental procedures and initiatives significantly contribute to this growth. The market also sees key trends for the forecast period such as advancements in biomaterials, the innovation of intelligent catheter technology, development of more potent catheter lock solutions harnessing superior antimicrobial features, catheter sterilization process enhancements, and automation of flushing systems.

What Is Contributing to the Growth of the Catheter-Related Bloodstream Infection Market?
The surge in hospital-obtained infections is projected to stimulate the expansion of the market for catheter-related bloodstream infections in the future. These are infections obtained by patients in a healthcare setting during the course of receiving treatment for other diseases, generally emerging 48 hours or later after admission. A rise in these conditions can be traced back to differing factors such as insufficient infection containment methods, antimicrobial resistance, and patient vulnerability. Catheter-associated bloodstream infections play a significant role in these hospital-obtained infections due to their intrusive characteristics and likelihood for microbial settlement, presenting dangers to patients with internal catheters. For example, the National Library of Medicine, a US-focused biomedical library, reported in January 2023 that the worldwide rate of healthcare-associated infections (HAI) stood at 0.14%, growing yearly by 0.06%. Consequently, the escalating prevalence of hospital-obtained infections is set to fuel the advancement of the catheter-related bloodstream infection market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

Who Are the Major Industry Players Fueling Catheter-Related Bloodstream Infection Market Expansion?
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Which Key Developments Are Influencing the Catheter-Related Bloodstream Infection Market?
Leading organizations in the catheter-related bloodstream infection market are making strides in creating innovative catheter lock solutions to bolster infection prevention and elevate patient care. Catheter lock solutions are fluids instilled inside catheters to curb infections and uphold catheter patency in between its applications. For example, in November 2023, CorMedix Inc., a biopharmaceutical firm based in the U.S. focusing on the creation and distribution of therapeutic products, obtained endorsement from the US Food and Drug Administration for DefenCath (taurolidine and heparin), a catheter lock solution meant for adult patients suffering from kidney failure who are undergoing chronic hemodialysis through a central venous catheter (CVC). This solution, which has both antimicrobial and antifungal properties, has been designed to decrease catheter-related bloodstream infections (CRBSIs). It utilizes heparin for anticoagulation and incorporates the wide-ranging antimicrobial traits of taurolidine.

How Is the Segmentation of the Catheter-Related Bloodstream Infection Market Defined?
The catheter-related bloodstream infection market covered in this report is segmented -

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

What Is the Leading Region in the Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Catheter-Related Bloodstream Infection Global Market Report?

- Market Size Analysis: Analyze the Catheter-Related Bloodstream Infection Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Catheter-Related Bloodstream Infection Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Catheter-Related Bloodstream Infection Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Catheter-Related Bloodstream Infection Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.